Cefalu WT, Stenlf K, Leiter LA, et al
What actually happens when you take GLP-1 a day early Understanding the theory is useful
Scand J Gastroenterol 2023
Research in earlier phases or small trials include evaluation of GLP-1s for indications such as cystic fibrosis-related diabetes, polycystic ovarian syndrome (PCOS), chronic obstructive pulmonary disease (COPD), Prader-Willi syndrome (PWS), asthma, substance or alcohol use disorder, and as add-on to insulin for type 1 diabetes
In rare cases, they may lead to more serious reactions, including pancreatitis, gallbladder issues, kidney problems, or severe gastrointestinal symptoms
If youre pregnant, breastfeeding, on medication, or have a medical condition, make sure to discuss this with your doctor first